Genomab Biotech

New York, United States Founded: 2015 • Age: 11 yrs
Developer of humanized mouse models for preclinical studies and precision medicine

About Genomab Biotech

Genomab Biotech is a Healthcare company based in New York (United States) founded in 2015. Developer of humanized mouse models for preclinical studies and precision medicine. Genomab Biotech offers products and services including Human Immune System (HIS) Mice, Myeloid-enhanced HIS Mouse Models, and Personalized HIS Mice. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Animal Models. Its legal entity is Genomab Biotech Corp. Its competitors include Yecuris, zPREDICTA and Sagres Discovery; 3 of its 3 listed competitors have raised funding.

Company details

Genomab Biotech was founded in 2015 and is based in New York, United States. Humanized mouse models are created by the company for applications in preclinical studies. These models facilitate research in precision medicine within the biotechnology sector. Operations are centered on providing tools for therapeutic development and scientific investigations, with the domain genomab.com serving as the primary online presence.

Products & Services of Genomab Biotech

Genomab Biotech offers a comprehensive portfolio of products and services, including Human Immune System (HIS) Mice, Myeloid-enhanced HIS Mouse Models, and Personalized HIS Mice.

Human Immune System (HIS) Mice
Research Platform

Mouse models for simulating human immune responses in drug testing.

Myeloid-enhanced HIS Mouse Models
Advanced Research Tools

Enhanced models for studying myeloid cells in immune system research.

Personalized HIS Mice
Custom Research Solutions

Tailored mouse models for specific translational and precision medicine applications.

Competitors of Genomab Biotech

Genomab Biotech has 3 listed competitors in our database, 3 of them funded. They include Yecuris, zPREDICTA and Sagres Discovery.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
yecuris.com2007Tualatin, United States$1.25M26
Humanized liver rodent models are developed for biology research.
zpredicta.com2014San Jose, United States$220,0003
Tumor-specific in vitro 3D models are supplied for drug development.
sagresdiscovery.com2000Davis, United States$20M
Creates innovative mouse models to analyze genes causing cancer diseases.
Premium access

Detailed competitors of Genomab Biotech

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Genomab Biotech (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Genomab Biotech

Genomab Biotech was founded in 2015.

Genomab Biotech is headquartered in New York, United States. It is registered at New York, New York, United States.

Genomab Biotech was founded in 2015 and is based in New York, United States. Humanized mouse models are created by the company for applications in preclinical studies. These models facilitate research in precision medicine within the biotechnology sector. Operations are centered on providing tools for therapeutic development and scientific investigations, with the domain genomab.com serving as the primary online presence.

Genomab Biotech's top competitors include Yecuris, zPREDICTA and Sagres Discovery.

Genomab Biotech offers Human Immune System (HIS) Mice, Myeloid-enhanced HIS Mouse Models, and Personalized HIS Mice.

Genomab Biotech operates through Genomab Biotech Corp.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available